Benzoic acid, 4,5-dihydroxy-2-methyl-, (2S)-3-[[1,1-dimethyl-2-[[(tetrahydro-3-furanyl)carbonyl]amino]ethyl]amino]-2-[[(1-methylcyclopropyl)carbonyl]oxy]propyl ester manufacturers
- Ot-730
-
- $195.00
-
2026-05-11
- CAS:870809-51-1
- Purity: 99.36%
- Supply Ability: 10g
|
| | Benzoic acid, 4,5-dihydroxy-2-methyl-, (2S)-3-[[1,1-dimethyl-2-[[(tetrahydro-3-furanyl)carbonyl]amino]ethyl]amino]-2-[[(1-methylcyclopropyl)carbonyl]oxy]propyl ester Basic information |
| | Benzoic acid, 4,5-dihydroxy-2-methyl-, (2S)-3-[[1,1-dimethyl-2-[[(tetrahydro-3-furanyl)carbonyl]amino]ethyl]amino]-2-[[(1-methylcyclopropyl)carbonyl]oxy]propyl ester Chemical Properties |
| Boiling point | 714.9±60.0 °C(Predicted) | | density | 1.270±0.06 g/cm3(Predicted) | | pka | 8.02±0.25(Predicted) |
| | Benzoic acid, 4,5-dihydroxy-2-methyl-, (2S)-3-[[1,1-dimethyl-2-[[(tetrahydro-3-furanyl)carbonyl]amino]ethyl]amino]-2-[[(1-methylcyclopropyl)carbonyl]oxy]propyl ester Usage And Synthesis |
| Uses | OT-730 is an innovative selective beta-blocker prodrug designed for research into ocular diseases. |
| | Benzoic acid, 4,5-dihydroxy-2-methyl-, (2S)-3-[[1,1-dimethyl-2-[[(tetrahydro-3-furanyl)carbonyl]amino]ethyl]amino]-2-[[(1-methylcyclopropyl)carbonyl]oxy]propyl ester Preparation Products And Raw materials |
|